CTA Head and Neck: Comprehensive Overview
Primary Indications
CTA of the head and neck is the imaging modality of choice for rapid, non-invasive evaluation of cerebrovascular emergencies, particularly acute stroke, subarachnoid hemorrhage, intracranial aneurysms, and vascular malformations. 1, 2
CTA Head Indications:
- Acute subarachnoid hemorrhage (SAH): CTA head demonstrates >90% sensitivity and specificity for detecting aneurysms responsible for SAH 2
- Intracerebral hemorrhage (ICH): Identifies underlying vascular lesions (aneurysms, arteriovenous malformations) with sensitivity and specificity exceeding 90% compared to catheter angiography 1
- CTA spot sign detection: Useful for prognosis in intracerebral hemorrhage 1
- Acute stroke evaluation: Identifies vessel occlusion, dissection, and atherosclerotic disease 3, 4
- Blunt head trauma: Rapid vascular assessment in emergency settings 4
CTA Neck Indications:
- Treatment planning: Useful when endovascular management is anticipated for intracranial pathology 1
- Cervical vascular trauma: Evaluation of blunt neck trauma 4
- Extracranial steno-occlusive disease: Assessment of carotid and vertebral artery stenosis 3
Important caveat: CTA head sensitivity decreases for aneurysms <3mm, in diffuse SAH, and for aneurysms adjacent to bone 2. In perimesencephalic hemorrhage with negative CTA, the study may be sufficient to rule out vascular causes, but catheter angiography is indicated for CTA-negative diffuse or peripheral SAH 2.
Technique and Protocol
Contrast Administration:
- High-density contrast media (400 mg I/ml) at optimal flow rate of 4 ml/s 3
- Low contrast volume protocols are feasible with modern multi-detector CT scanners 3
- Saline flushing following contrast administration improves vessel opacification 3
- Proper timing of data acquisition is critical for diagnostic quality 3
Technical Parameters:
- 16 and 64-row MDCT scanners enable extended non-invasive examinations with reduced contrast volume 3
- 3D reconstruction capabilities enhance visualization of vascular anatomy and pathology 5, 3
- Rapid acquisition time: Major advantage in acute neurologic emergencies 4
Alternative Contrast Agent:
- Gadolinium-enhanced CTA can be used in patients with contraindications to iodinated contrast agents 6
Contraindications
Absolute Contraindications:
- Severe iodinated contrast allergy (unless gadolinium alternative is used) 6
- Severe renal insufficiency requiring consideration of contrast-induced nephropathy risk 7
Relative Contraindications:
- Pregnancy: Radiation exposure and contrast administration require risk-benefit assessment 7
- Contrast-induced nephropathy risk: Requires pre-procedure risk stratification 7
- Inability to cooperate: Motion artifact significantly degrades image quality 4
Patient Preparation
- Renal function assessment: Obtain creatinine/eGFR before contrast administration 7
- Allergy history: Screen for prior contrast reactions 7
- IV access: Large-bore peripheral IV (18-20 gauge) for adequate flow rates 3
- Patient positioning: Proper positioning to minimize motion artifact 4
- Minimal preparation time: Critical advantage in emergency settings where rapid diagnosis impacts treatment decisions 4
Advantages Over Alternative Imaging
CTA offers several advantages over digital subtraction angiography (DSA) and MRA: 3
- Non-invasiveness compared to catheter angiography
- Delineation of vessel calcification
- Virtual independence from hemodynamic conditions
- Quantification without magnification correction
- Faster acquisition than MRA
- No safety screening requirements (unlike MRI)
Common pitfall: While CTA has largely replaced DSA for diagnostic purposes, catheter angiography remains superior for very small aneurysms (<3mm) and may identify vascular abnormalities in up to 13% of patients with SAH and negative CTA 2. DSA is now primarily reserved for endovascular treatment applications 3.
Clinical Decision-Making Algorithm
- Acute neurologic symptoms or suspected SAH: CTA head is first-line vascular imaging 2, 4
- Intracerebral hemorrhage: CTA head for underlying vascular etiology evaluation 1
- Negative CTA with high clinical suspicion: Consider catheter angiography, especially for diffuse/peripheral SAH 2
- Treatment planning for endovascular intervention: Add CTA neck to evaluate access routes 1
- Contraindication to iodinated contrast: Consider gadolinium-enhanced CTA or MRA alternatives 6